Latest News

• share
• favorite_border

Researchers have been awarded a $3.1 million grant from the National Institutes of Health to investigate more effective ways to identify ovarian cancer earlier.

• share
• favorite_border

Nearly 10 million cancer screenings in the U.S. failed to happen because of the COVID-19 pandemic, according to a study published in JAMA Oncology, a publication of the American Medical Association.

• share
• favorite_border

Carol Fabian, MD, FASCO, a nationally recognized medical oncologist and breast cancer researcher, has been named a Fellow of the American Society of Clinical Oncology (FASCO).

• share
• favorite_border

The University of Kansas Cancer Center is the first and only site in the region to offer CAR T-cell therapy to treat multiple myeloma, a type of blood cancer that affects about 30,000 people each year.

• share
• favorite_border

The University of Kansas Cancer Center is part of a nationwide effort to resume appropriate cancer screening and treatment to prevent excess deaths.

• share
• favorite_border

Researchers from The University of Kansas Cancer Center are involved in the presentation of nearly 50 research studies at the 62nd American Society of Hematology (ASH) Annual Meeting.

• share
• favorite_border

Men with cancer and COVID-19 may be at significantly higher risk for severe symptoms and even death as compared to females fighting both, a University of Kansas Cancer Center research team has found.

• share
• favorite_border

Scientists and medical professionals have long debated whether pod e-cigarettes are a safer alternative to traditional cigarettes. A new study provides some insight.

• share
• favorite_border

In one year, The University of Kansas Cancer Center will submit its application to renew its prestigious National Cancer Institute (NCI) designation in the hopes of attaining “comprehensive” status, the NCI’s highest ranking.

• share
• favorite_border

The University of Kansas Cancer Center’s status as a community site of the National Cancer Institute’s Community Oncology Research Program has been renewed after exceeding clinical trial accrual goals by more than 22% in its first year.

• share
• favorite_border

The University of Kansas Medical Center announced today a trial exploring a drug intended to fight the cytokine storm common in COVID-19.

• share
• favorite_border

Danny Welch, PhD, researcher at The University of Kansas Cancer Center, studies metastasis, which is responsible for more than 90% of cancer-related deaths.

• share
• favorite_border

Dr. Chen joins a group of just 19 physicians and medical physicists who are recognized this year for their contributions to the field of radiation oncology.

• share
• favorite_border

Physicians and scientists at The University of Kansas Cancer Center are committed to improving lung cancer outcomes in Kansas.

• share
• favorite_border

Researchers at The University of Kansas Cancer Center are studying vaping to better understand its effects on our health, as well as reduce vaping among adolescents.

• share
• favorite_border

The University of Kansas Cancer Center is helping fight the pandemic in numerous ways.

• share
• favorite_border

Ronald Chen, MD, MPH, has been named a Fellow of the American Society of Clinical Oncology (FASCO) in honor of his extraordinary volunteer service, dedication and commitment to ASCO.

• share
• favorite_border

KU Medical Center is one of 60 sites across the nation that will be participating in this clinical trial, led by the Duke Clinical Research Institute.

• share
• favorite_border

The University of Kansas Cancer Center will receive an additional $5 million from the state budget for the KU Cancer Center Research Fund.

• share
• favorite_border

The University of Kansas Cancer Center has partnered with Fox4 and the Kansas City Kansas School district to host a town hall on vaping at Sumner Academy February 27.